Back to search

Article

Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome

2020-07-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> It has been reported that the high-dosage administration of domestically approved pharmaceutical drugs, especially granulocyte colony-stimulating factor (G-CSF) and romiplostim (RP), is a rapid and appropriate medical treatment for preventing severe acute radiation syndrome (ARS) of victims exposed to lethal total-body irradiation (TBI). However, it remains uncl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9179da7-5420-54b4-8b8c-357226ca35cc
DOI
10.21203/rs.3.rs-34653/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndromeDOI 10.21203/rs.3.rs-34653/v2
Select a neighboring publication to make it the new centre.